^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    BCD-245

    i
    Other names: BCD-245, BCD 245
    Associations

    News

    Trials
    Company:
    Biocad
    Drug class:
    GD2 ganglioside inhibitor
    Related drugs:
    Associations

    News

    Trials
    over1year
    Phase 1 Study of BCD-245 in Subjects With Neuroblastoma (clinicaltrials.gov)
    P1, N=24, Recruiting, Biocad
    New P1 trial
    |
    NCAM1 (Neural cell adhesion molecule 1)
    |
    BCD-245